|
Chief Executive Officer (CEO) of Novartis Vaccines and Diagnostics Member of the Executive Committee of Novartis Joerg Reinhardt is CEO of the Novartis Vaccines and Diagnostics Division. He is also a member of the Executive Committee of Novartis. Previously, Joerg Reinhardt was Global Head of Development in the
Novartis Pharmaceuticals Division, overseeing clinical, pharmaceutical, chemical and biotechnological product development, drug safety assessment and regulatory affairs. Under his leadership, Novartis achieved an outstanding record in development quality, speed and productivity, resulting in a full product pipeline recognized as one of the most successful in the industry. He joined Sandoz, a predecessor company of Novartis, in 1982 and held various leadership positions in Research & Development for the company. In 1994 he was made Head of Corporate Development. He became Head of Preclinical Development and Project Management for Novartis in 1996, and took the position of Global Head of Development in 1999.
Joerg Reinhardt chairs the Board of Directors of the Genomics Institute of the Novartis Foundation in La Jolla, California. From 2001 to 2004, he served as a member of the Board of Directors of MorphoSys AG, Germany, a company specialized in research and development of monoclonal antibodies. He received his Ph.D. in Pharmaceutical Sciences from the University of Saarbr�cken, Germany. | 